The role of community pharmacists during the COVID-19 pandemic in the U.S.
Abstract
Keywords
References
- [1] Ciotti M, Angeletti S, Minieri M, Giovannetti M, Benvenuto D, Pascarella S, Sagnelli C, Bianchi M, Bernardini S, Ciccozzi M. COVID-19 Outbreak: An Overview. Chemotherapy. 2019; 64(5-6): 215-223.
- [2] WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media- briefing-on-covid-19---11-march-2020, (accessed on 12 June 2021).
- [3] Johns Hopkins Coronavirus Resource Center Mortality Analyses. coronavirus.jhu.edu/data/mortality (accessed on 24 Aug 2015).
- [4] Bashshur R, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 Pandemic, Lessons for the Future. Telemedicine and e-Health. 2020; 26(5): 571-573.
- [5] Toklu HZ. Promoting evidence-based practice in pharmacies. Integr Pharm Res Pract. 2015; 4: 127-131.
- [6]Toklu HZ. Eczacılık Uygulamalarında Akılcı İlaç Kullanımı. Türkiye Klinikleri J Pharmacol-Special Topics. 2015; 3(1): 74-83.
- [7] Toklu HZ. Pharmacovigilance of Herbal Medicine: Herbavigilance. Adv Pharmacoepidemiol Drug Saf. 2016; 5: 208.
- [8] Visacri MB, Figueiredo IV, Lima TM. Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Social Adm Pharm. 2021; 17(1): 1799-1806.
Details
Primary Language
English
Subjects
Clinical Pharmacy and Pharmacy Practice
Journal Section
Letter to Editor
Authors
Mehmed Bulend Ugur
*
This is me
United States
Irem Tutku Aslanbay Koc
Türkiye
Zeynep Sena Mus
This is me
Türkiye
Publication Date
June 28, 2025
Submission Date
July 1, 2021
Acceptance Date
September 4, 2021
Published in Issue
Year 2021 Volume: 25 Number: 6